

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.36492373 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.64408142 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.64408142 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.31352515 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.31352515 |
| 6 | omega-hydroxylase P450 pathway (GO:0097267) | 7.05206830 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.91198385 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.89973602 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.35663905 |
| 10 | oxidative demethylation (GO:0070989) | 6.29161062 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.24254564 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.24254564 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.24254564 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.10541707 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.87316682 |
| 16 | * bile acid biosynthetic process (GO:0006699) | 5.80469138 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.79658966 |
| 18 | urea cycle (GO:0000050) | 5.75160538 |
| 19 | urea metabolic process (GO:0019627) | 5.75160538 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.65124030 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62287750 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.60030226 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.44711076 |
| 24 | protein carboxylation (GO:0018214) | 5.42341062 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42341062 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.42304066 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.40651730 |
| 28 | cysteine metabolic process (GO:0006534) | 5.38924088 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.37309792 |
| 30 | drug metabolic process (GO:0017144) | 5.31457795 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.28832049 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.19986891 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 5.01861511 |
| 34 | regulation of complement activation (GO:0030449) | 5.01775337 |
| 35 | * bile acid metabolic process (GO:0008206) | 5.00884978 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.88870088 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87418808 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.86588559 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.85598161 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.84885306 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.84705546 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 4.84410251 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.79040654 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.79040654 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.79040654 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.69924056 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.65569532 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.65569532 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.61692224 |
| 50 | lysine metabolic process (GO:0006553) | 4.60158214 |
| 51 | lysine catabolic process (GO:0006554) | 4.60158214 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.59402117 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.59402117 |
| 54 | phospholipid efflux (GO:0033700) | 4.57074176 |
| 55 | phenylpropanoid metabolic process (GO:0009698) | 4.54816560 |
| 56 | glycine metabolic process (GO:0006544) | 4.49650112 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.44158876 |
| 58 | alkaloid metabolic process (GO:0009820) | 4.42594584 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.42111269 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.41942083 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.40171816 |
| 62 | amine catabolic process (GO:0009310) | 4.34187434 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.34187434 |
| 64 | cellular glucuronidation (GO:0052695) | 4.32016988 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 4.31818245 |
| 66 | glutamate metabolic process (GO:0006536) | 4.27331680 |
| 67 | cholesterol efflux (GO:0033344) | 4.25006924 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.22987715 |
| 69 | * bile acid and bile salt transport (GO:0015721) | 4.15819534 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 4.15615611 |
| 71 | ethanol oxidation (GO:0006069) | 4.14443053 |
| 72 | ethanol metabolic process (GO:0006067) | 4.12727274 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.08028975 |
| 74 | arginine metabolic process (GO:0006525) | 4.07043479 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06600456 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05331808 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 4.04322060 |
| 78 | fibrinolysis (GO:0042730) | 4.03083671 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 4.02468011 |
| 80 | aldehyde catabolic process (GO:0046185) | 4.01655625 |
| 81 | drug catabolic process (GO:0042737) | 3.93792703 |
| 82 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87337984 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.86003899 |
| 84 | amino acid salvage (GO:0043102) | 3.84840510 |
| 85 | L-methionine salvage (GO:0071267) | 3.84840510 |
| 86 | L-methionine biosynthetic process (GO:0071265) | 3.84840510 |
| 87 | cofactor catabolic process (GO:0051187) | 3.83865440 |
| 88 | glucuronate metabolic process (GO:0019585) | 3.83051678 |
| 89 | uronic acid metabolic process (GO:0006063) | 3.83051678 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80830476 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.79854726 |
| 92 | behavioral response to nicotine (GO:0035095) | 3.79363504 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78348859 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78348859 |
| 95 | carboxylic acid catabolic process (GO:0046395) | 3.76930210 |
| 96 | organic acid catabolic process (GO:0016054) | 3.76930210 |
| 97 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76725034 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.76596489 |
| 99 | complement activation (GO:0006956) | 3.76575931 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.76067428 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.75314081 |
| 102 | protein activation cascade (GO:0072376) | 3.74552228 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.74535700 |
| 104 | cytolysis (GO:0019835) | 3.72448715 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.71655715 |
| 106 | sterol homeostasis (GO:0055092) | 3.70262592 |
| 107 | short-chain fatty acid metabolic process (GO:0046459) | 3.67230111 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 3.66934314 |
| 109 | plasma lipoprotein particle organization (GO:0071827) | 3.63853609 |
| 110 | * cellular ketone body metabolic process (GO:0046950) | 3.62029181 |
| 111 | protein-lipid complex assembly (GO:0065005) | 3.60730468 |
| 112 | NAD biosynthetic process (GO:0009435) | 3.60589241 |
| 113 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.56966372 |
| 114 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56966372 |
| 115 | arginine catabolic process (GO:0006527) | 3.50796039 |
| 116 | opsonization (GO:0008228) | 3.49544927 |
| 117 | heme transport (GO:0015886) | 3.43777240 |
| 118 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39851600 |
| 119 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.34804494 |
| 120 | indole-containing compound metabolic process (GO:0042430) | 3.23360768 |
| 121 | regulation of plasminogen activation (GO:0010755) | 3.19334072 |
| 122 | * ketone body metabolic process (GO:1902224) | 3.17064197 |
| 123 | negative regulation of protein activation cascade (GO:2000258) | 3.14874204 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.11542876 |
| 125 | nucleobase catabolic process (GO:0046113) | 3.09965816 |
| 126 | methionine biosynthetic process (GO:0009086) | 3.06514496 |
| 127 | methionine metabolic process (GO:0006555) | 3.04712608 |
| 128 | response to misfolded protein (GO:0051788) | 3.03925737 |
| 129 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.98267995 |
| 130 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.98267995 |
| 131 | intestinal cholesterol absorption (GO:0030299) | 2.97235628 |
| 132 | peptidyl-glutamic acid modification (GO:0018200) | 2.96747730 |
| 133 | xenobiotic catabolic process (GO:0042178) | 2.92422663 |
| 134 | regulation of humoral immune response (GO:0002920) | 2.89584072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.43908234 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20281240 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.06294247 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52961338 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.34159328 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.15332392 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81303744 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06320692 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04432482 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.31744750 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 3.08681049 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.64830363 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42095731 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.40184543 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.11903617 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08599275 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06749152 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06609838 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9891087 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98923836 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96211722 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96124730 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.93279270 |
| 24 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.93041542 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92462335 |
| 26 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.64525066 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.63082206 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61723415 |
| 29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59466594 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57912085 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54984698 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.54027757 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52972842 |
| 34 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47144803 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46752108 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46090418 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.43146920 |
| 38 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39913969 |
| 39 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39755473 |
| 40 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39733064 |
| 41 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39733064 |
| 42 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.38110354 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37673302 |
| 44 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.36879813 |
| 45 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.34891469 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.34890430 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.33269634 |
| 48 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.33269634 |
| 49 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32738991 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32357513 |
| 51 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.32097112 |
| 52 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.32097112 |
| 53 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.29686552 |
| 54 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28296820 |
| 55 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27933341 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27055942 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24685671 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24176567 |
| 59 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22639427 |
| 60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21645718 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21539630 |
| 62 | ERA_21632823_ChIP-Seq_H3396_Human | 1.21224842 |
| 63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20964009 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20453368 |
| 65 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.20138566 |
| 66 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19948601 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19126786 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17087629 |
| 69 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17031758 |
| 70 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15265010 |
| 71 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13329105 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13174391 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13174391 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12969029 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12269280 |
| 76 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12260990 |
| 77 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09928650 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09156872 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08240267 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07030850 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06845065 |
| 82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05242158 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04560776 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04281640 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03163370 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03044842 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00248990 |
| 88 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00125352 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00086274 |
| 90 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99411543 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99127047 |
| 92 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.98677857 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97422887 |
| 94 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96141415 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96125166 |
| 96 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95719666 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95459234 |
| 98 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.94411862 |
| 99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94028006 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91566877 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90338446 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83604856 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82187191 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82113547 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80917941 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79163943 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79151588 |
| 108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78803186 |
| 109 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77668686 |
| 110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77118607 |
| 111 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77068500 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76751511 |
| 113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76193280 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73274085 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72135275 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70440480 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67095689 |
| 118 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66203113 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65790056 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65228394 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63100032 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62989842 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62989842 |
| 124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62405451 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62248802 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61353883 |
| 127 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59445827 |
| 128 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.58440707 |
| 129 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.57250048 |
| 130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56780846 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53493199 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53471551 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52147905 |
| 134 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.51869666 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51629777 |
| 136 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51007797 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50683604 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50651269 |
| 139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50274940 |
| 140 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49416508 |
| 141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47506769 |
| 142 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47466216 |
| 143 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45930404 |
| 144 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45365368 |
| 145 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44534683 |
| 146 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43898108 |
| 147 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42621550 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42395837 |
| 149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41728820 |
| 150 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41636841 |
| 151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41132814 |
| 152 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40957118 |
| 153 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40787401 |
| 154 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40649269 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39533967 |
| 156 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39113006 |
| 157 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38604184 |
| 158 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38317704 |
| 159 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38132620 |
| 160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38096334 |
| 161 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37993467 |
| 162 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37809426 |
| 163 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36979850 |
| 164 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.36392343 |
| 165 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36187070 |
| 166 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.35522042 |
| 167 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35054780 |
| 168 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34209019 |
| 169 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.34090686 |
| 170 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33408629 |
| 171 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.32561957 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.32350303 |
| 173 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32233171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.38303773 |
| 2 | MP0005360_urolithiasis | 7.60299202 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.25734762 |
| 4 | MP0005365_abnormal_bile_salt | 6.24315993 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.20647577 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.29769508 |
| 7 | MP0003252_abnormal_bile_duct | 3.94215108 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.61253697 |
| 9 | MP0009840_abnormal_foam_cell | 3.32079633 |
| 10 | MP0005083_abnormal_biliary_tract | 3.10445470 |
| 11 | MP0003195_calcinosis | 2.84284405 |
| 12 | MP0005332_abnormal_amino_acid | 2.77388970 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59891620 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.30322152 |
| 15 | * MP0000609_abnormal_liver_physiology | 2.15074339 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14684210 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.08751325 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.95063551 |
| 19 | MP0003868_abnormal_feces_composition | 1.94443433 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84442044 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 1.80670078 |
| 22 | MP0006292_abnormal_olfactory_placode | 1.70421222 |
| 23 | MP0001764_abnormal_homeostasis | 1.69287389 |
| 24 | MP0001986_abnormal_taste_sensitivity | 1.69244134 |
| 25 | MP0009697_abnormal_copulation | 1.62031406 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.60553478 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57170008 |
| 28 | MP0004043_abnormal_pH_regulation | 1.51258866 |
| 29 | MP0005451_abnormal_body_composition | 1.46415256 |
| 30 | MP0003646_muscle_fatigue | 1.46409343 |
| 31 | MP0009745_abnormal_behavioral_response | 1.42008861 |
| 32 | MP0003011_delayed_dark_adaptation | 1.39772280 |
| 33 | MP0004142_abnormal_muscle_tone | 1.39039720 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.35844719 |
| 35 | MP0002736_abnormal_nociception_after | 1.30640000 |
| 36 | MP0003186_abnormal_redox_activity | 1.27325816 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.26549928 |
| 38 | MP0003136_yellow_coat_color | 1.26328299 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.21264248 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.17673237 |
| 41 | MP0009046_muscle_twitch | 1.16982233 |
| 42 | * MP0000598_abnormal_liver_morphology | 1.16264373 |
| 43 | MP0005647_abnormal_sex_gland | 1.15812213 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.15064405 |
| 45 | MP0004147_increased_porphyrin_level | 1.13587305 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.13359309 |
| 47 | MP0002102_abnormal_ear_morphology | 1.12786658 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.08067792 |
| 49 | MP0000604_amyloidosis | 1.07443435 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.05900794 |
| 51 | MP0009764_decreased_sensitivity_to | 1.05524553 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.05485099 |
| 53 | MP0009763_increased_sensitivity_to | 1.02277793 |
| 54 | MP0002272_abnormal_nervous_system | 1.02161889 |
| 55 | MP0002254_reproductive_system_inflammat | 1.00926061 |
| 56 | MP0006276_abnormal_autonomic_nervous | 0.97748662 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 0.97286817 |
| 58 | MP0002735_abnormal_chemical_nociception | 0.94289370 |
| 59 | MP0010368_abnormal_lymphatic_system | 0.93055625 |
| 60 | MP0004133_heterotaxia | 0.90706825 |
| 61 | MP0002064_seizures | 0.89990570 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.89747248 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 0.89097847 |
| 64 | MP0003878_abnormal_ear_physiology | 0.89097847 |
| 65 | MP0001984_abnormal_olfaction | 0.88814766 |
| 66 | MP0002938_white_spotting | 0.88705582 |
| 67 | MP0008469_abnormal_protein_level | 0.88673727 |
| 68 | MP0005253_abnormal_eye_physiology | 0.87195306 |
| 69 | MP0000427_abnormal_hair_cycle | 0.86849599 |
| 70 | * MP0009642_abnormal_blood_homeostasis | 0.85946196 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.85822390 |
| 72 | MP0001486_abnormal_startle_reflex | 0.85735619 |
| 73 | MP0005408_hypopigmentation | 0.84327916 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 0.82118237 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 0.81957160 |
| 76 | MP0005187_abnormal_penis_morphology | 0.81167366 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 0.81053359 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.80482923 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.80087835 |
| 80 | MP0005670_abnormal_white_adipose | 0.79587510 |
| 81 | MP0002572_abnormal_emotion/affect_behav | 0.79439117 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.78273724 |
| 83 | MP0003879_abnormal_hair_cell | 0.76575606 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.75154865 |
| 85 | * MP0002078_abnormal_glucose_homeostasis | 0.74710620 |
| 86 | MP0002234_abnormal_pharynx_morphology | 0.74518085 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 0.74210635 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.72865341 |
| 89 | MP0002971_abnormal_brown_adipose | 0.72240884 |
| 90 | MP0002282_abnormal_trachea_morphology | 0.70782199 |
| 91 | MP0002557_abnormal_social/conspecific_i | 0.70746332 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.70108090 |
| 93 | MP0004130_abnormal_muscle_cell | 0.69536641 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.69035408 |
| 95 | MP0004924_abnormal_behavior | 0.68789759 |
| 96 | MP0005386_behavior/neurological_phenoty | 0.68789759 |
| 97 | MP0004885_abnormal_endolymph | 0.68396302 |
| 98 | MP0001661_extended_life_span | 0.67765278 |
| 99 | MP0003690_abnormal_glial_cell | 0.67718556 |
| 100 | MP0001970_abnormal_pain_threshold | 0.67559742 |
| 101 | MP0005195_abnormal_posterior_eye | 0.66511148 |
| 102 | MP0005266_abnormal_metabolism | 0.66064769 |
| 103 | MP0009053_abnormal_anal_canal | 0.65943192 |
| 104 | MP0002160_abnormal_reproductive_system | 0.64786340 |
| 105 | MP0003787_abnormal_imprinting | 0.64046497 |
| 106 | MP0003880_abnormal_central_pattern | 0.63777909 |
| 107 | MP0003329_amyloid_beta_deposits | 0.62991122 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.62314743 |
| 109 | MP0000631_abnormal_neuroendocrine_gland | 0.61398604 |
| 110 | * MP0005334_abnormal_fat_pad | 0.60600560 |
| 111 | MP0008995_early_reproductive_senescence | 0.59804255 |
| 112 | MP0005410_abnormal_fertilization | 0.59787973 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.59779351 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.56823456 |
| 115 | MP0001756_abnormal_urination | 0.56622841 |
| 116 | * MP0005535_abnormal_body_temperature | 0.55990457 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.52688355 |
| 118 | MP0002822_catalepsy | 0.49304433 |
| 119 | MP0005395_other_phenotype | 0.49153035 |
| 120 | MP0003718_maternal_effect | 0.48958106 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.46419920 |
| 122 | MP0008874_decreased_physiological_sensi | 0.46373044 |
| 123 | MP0008873_increased_physiological_sensi | 0.45495577 |
| 124 | MP0002928_abnormal_bile_duct | 0.45186529 |
| 125 | * MP0005448_abnormal_energy_balance | 0.44243881 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.44146948 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.43205268 |
| 128 | MP0003436_decreased_susceptibility_to | 0.42424084 |
| 129 | MP0003724_increased_susceptibility_to | 0.41466458 |
| 130 | MP0004381_abnormal_hair_follicle | 0.41061308 |
| 131 | MP0005248_abnormal_Harderian_gland | 0.40847824 |
| 132 | MP0003075_altered_response_to | 0.40687815 |
| 133 | MP0002837_dystrophic_cardiac_calcinosis | 0.39126177 |
| 134 | * MP0003953_abnormal_hormone_level | 0.38244732 |
| 135 | MP0008872_abnormal_physiological_respon | 0.37902912 |
| 136 | MP0005166_decreased_susceptibility_to | 0.37478201 |
| 137 | MP0000579_abnormal_nail_morphology | 0.37401397 |
| 138 | MP0009672_abnormal_birth_weight | 0.36949751 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.36589635 |
| 140 | MP0002796_impaired_skin_barrier | 0.34035972 |
| 141 | MP0009115_abnormal_fat_cell | 0.33605994 |
| 142 | MP0006082_CNS_inflammation | 0.33281108 |
| 143 | MP0000249_abnormal_blood_vessel | 0.31844086 |
| 144 | MP0001243_abnormal_dermal_layer | 0.31359185 |
| 145 | MP0002970_abnormal_white_adipose | 0.30990900 |
| 146 | MP0002168_other_aberrant_phenotype | 0.30468803 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.30318006 |
| 148 | MP0004883_abnormal_blood_vessel | 0.30255075 |
| 149 | MP0001853_heart_inflammation | 0.30221310 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.29999325 |
| 151 | MP0001881_abnormal_mammary_gland | 0.27556369 |
| 152 | MP0001845_abnormal_inflammatory_respons | 0.27486966 |
| 153 | MP0002060_abnormal_skin_morphology | 0.24693549 |
| 154 | MP0002132_abnormal_respiratory_system | 0.24146692 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.24076825 |
| 156 | MP0005164_abnormal_response_to | 0.23881918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.47445254 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46785323 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.35829527 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.74637265 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.62882185 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.51482618 |
| 7 | Xanthomatosis (HP:0000991) | 6.30932957 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.62808310 |
| 9 | Complement deficiency (HP:0004431) | 5.40174655 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.83603182 |
| 11 | Joint hemorrhage (HP:0005261) | 4.83345337 |
| 12 | Hyperammonemia (HP:0001987) | 4.62249104 |
| 13 | Epidermoid cyst (HP:0200040) | 4.57243678 |
| 14 | Hyperglycinemia (HP:0002154) | 4.46169053 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45325098 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42290804 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.34094195 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27868575 |
| 19 | Ketosis (HP:0001946) | 4.24888242 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.19601716 |
| 21 | Fat malabsorption (HP:0002630) | 4.15507774 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15215064 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14743912 |
| 24 | Abnormality of complement system (HP:0005339) | 3.94270220 |
| 25 | Hyperglycinuria (HP:0003108) | 3.93003559 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.91980191 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91980191 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.89507300 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.81320948 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77942809 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74691652 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.65001571 |
| 33 | Pancreatic cysts (HP:0001737) | 3.61137275 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37370278 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.35015855 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31676771 |
| 37 | Pancreatic fibrosis (HP:0100732) | 3.22522705 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 3.14806134 |
| 39 | Hyperalaninemia (HP:0003348) | 3.14806134 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.14806134 |
| 41 | Fair hair (HP:0002286) | 3.14058076 |
| 42 | Steatorrhea (HP:0002570) | 3.13840671 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.11499462 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 3.10162761 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 3.07366857 |
| 46 | Molar tooth sign on MRI (HP:0002419) | 3.07366857 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06754222 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 3.03320347 |
| 49 | Spontaneous abortion (HP:0005268) | 3.01066340 |
| 50 | Myocardial infarction (HP:0001658) | 2.99081782 |
| 51 | Ketoacidosis (HP:0001993) | 2.99063221 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.98941370 |
| 53 | Congenital stationary night blindness (HP:0007642) | 2.95510954 |
| 54 | True hermaphroditism (HP:0010459) | 2.92044697 |
| 55 | Hyperventilation (HP:0002883) | 2.86754322 |
| 56 | Bile duct proliferation (HP:0001408) | 2.81795628 |
| 57 | Abnormal biliary tract physiology (HP:0012439) | 2.81795628 |
| 58 | Skin nodule (HP:0200036) | 2.81645860 |
| 59 | Chronic hepatic failure (HP:0100626) | 2.77338754 |
| 60 | Metabolic acidosis (HP:0001942) | 2.74139520 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.73245714 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.65377684 |
| 63 | Nephronophthisis (HP:0000090) | 2.61830077 |
| 64 | Lethargy (HP:0001254) | 2.61044143 |
| 65 | Acanthocytosis (HP:0001927) | 2.57852187 |
| 66 | Vascular calcification (HP:0004934) | 2.57194605 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.55614750 |
| 68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55614750 |
| 69 | Abnormality of the renal cortex (HP:0011035) | 2.54958535 |
| 70 | Attenuation of retinal blood vessels (HP:0007843) | 2.52302983 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.48401379 |
| 72 | Spastic diplegia (HP:0001264) | 2.48053090 |
| 73 | Cystic liver disease (HP:0006706) | 2.46892024 |
| 74 | Glomerulonephritis (HP:0000099) | 2.45947903 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.44689545 |
| 76 | Mitral stenosis (HP:0001718) | 2.42308396 |
| 77 | Gout (HP:0001997) | 2.41881409 |
| 78 | Cerebral edema (HP:0002181) | 2.41827118 |
| 79 | Cholelithiasis (HP:0001081) | 2.41562684 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.37177202 |
| 81 | Cholecystitis (HP:0001082) | 2.37177202 |
| 82 | Irritability (HP:0000737) | 2.36909522 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36601067 |
| 84 | Neonatal onset (HP:0003623) | 2.35038439 |
| 85 | Generalized hypopigmentation of hair (HP:0011358) | 2.31023258 |
| 86 | Type II lissencephaly (HP:0007260) | 2.29567602 |
| 87 | Cardiovascular calcification (HP:0011915) | 2.27742149 |
| 88 | Amyloidosis (HP:0011034) | 2.26428472 |
| 89 | Abolished electroretinogram (ERG) (HP:0000550) | 2.26215764 |
| 90 | Malnutrition (HP:0004395) | 2.24932500 |
| 91 | Abnormality of the renal medulla (HP:0100957) | 2.22026496 |
| 92 | Esophageal varix (HP:0002040) | 2.20792603 |
| 93 | Gingival bleeding (HP:0000225) | 2.20131738 |
| 94 | Genetic anticipation (HP:0003743) | 2.16354093 |
| 95 | Menorrhagia (HP:0000132) | 2.16279648 |
| 96 | Brushfield spots (HP:0001088) | 2.14564437 |
| 97 | Glycosuria (HP:0003076) | 2.12669849 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 2.12669849 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.12236660 |
| 100 | Pancreatitis (HP:0001733) | 2.11481792 |
| 101 | Late onset (HP:0003584) | 2.09997482 |
| 102 | Progressive cerebellar ataxia (HP:0002073) | 2.09704202 |
| 103 | Acute encephalopathy (HP:0006846) | 2.08812723 |
| 104 | Enlarged kidneys (HP:0000105) | 2.08676499 |
| 105 | Medial flaring of the eyebrow (HP:0010747) | 2.08577971 |
| 106 | Decreased central vision (HP:0007663) | 2.08356476 |
| 107 | Thrombophlebitis (HP:0004418) | 2.07337470 |
| 108 | Vomiting (HP:0002013) | 2.04731536 |
| 109 | Opisthotonus (HP:0002179) | 2.04105280 |
| 110 | Pendular nystagmus (HP:0012043) | 2.02609774 |
| 111 | Poikilocytosis (HP:0004447) | 2.01600091 |
| 112 | Abnormality of the gallbladder (HP:0005264) | 2.01392582 |
| 113 | Generalized aminoaciduria (HP:0002909) | 2.00670607 |
| 114 | Hemorrhage of the eye (HP:0011885) | 1.99861192 |
| 115 | Tubular atrophy (HP:0000092) | 1.98548565 |
| 116 | Large for gestational age (HP:0001520) | 1.98202165 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97372405 |
| 118 | Gaze-evoked nystagmus (HP:0000640) | 1.95428544 |
| 119 | Rickets (HP:0002748) | 1.93984235 |
| 120 | Reduced antithrombin III activity (HP:0001976) | 1.91674648 |
| 121 | Arthropathy (HP:0003040) | 1.91495446 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 1.88504327 |
| 123 | Congenital hepatic fibrosis (HP:0002612) | 1.88377607 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.88020561 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.87029618 |
| 126 | Inability to walk (HP:0002540) | 1.85813202 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85125831 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 1.84672062 |
| 129 | Renal cortical cysts (HP:0000803) | 1.84144540 |
| 130 | Sclerocornea (HP:0000647) | 1.83975373 |
| 131 | Hydroxyprolinuria (HP:0003080) | 1.82450075 |
| 132 | Abnormality of proline metabolism (HP:0010907) | 1.82450075 |
| 133 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82263378 |
| 134 | Alkalosis (HP:0001948) | 1.80975544 |
| 135 | Status epilepticus (HP:0002133) | 1.80487597 |
| 136 | Elevated hepatic transaminases (HP:0002910) | 1.80295255 |
| 137 | Increased CSF lactate (HP:0002490) | 1.80112658 |
| 138 | Birth length less than 3rd percentile (HP:0003561) | 1.79845749 |
| 139 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76665297 |
| 140 | Nephritis (HP:0000123) | 1.75236530 |
| 141 | Abnormal drinking behavior (HP:0030082) | 1.74731645 |
| 142 | Polydipsia (HP:0001959) | 1.74731645 |
| 143 | Abnormality of vitamin metabolism (HP:0100508) | 1.73881068 |
| 144 | Acute necrotizing encephalopathy (HP:0006965) | 1.73725399 |
| 145 | Hyperglycemia (HP:0003074) | 1.73614805 |
| 146 | Hepatic necrosis (HP:0002605) | 1.73511489 |
| 147 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.73082982 |
| 148 | Absent/shortened dynein arms (HP:0200106) | 1.73082982 |
| 149 | Chorioretinal atrophy (HP:0000533) | 1.72960386 |
| 150 | Male pseudohermaphroditism (HP:0000037) | 1.71761067 |
| 151 | Methylmalonic aciduria (HP:0012120) | 1.71547227 |
| 152 | Mitochondrial inheritance (HP:0001427) | 1.71323709 |
| 153 | Severe muscular hypotonia (HP:0006829) | 1.70741487 |
| 154 | Neonatal hypoglycemia (HP:0001998) | 1.67745390 |
| 155 | Protruding tongue (HP:0010808) | 1.67588939 |
| 156 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.67314068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.16634742 |
| 2 | SIK1 | 4.62151947 |
| 3 | FGFR4 | 4.60934498 |
| 4 | ERN1 | 4.29044051 |
| 5 | BMPR1B | 3.37011391 |
| 6 | TAOK3 | 3.07774614 |
| 7 | ADRBK2 | 3.07253290 |
| 8 | ACVR1B | 3.03287907 |
| 9 | ZAK | 3.02884000 |
| 10 | ERBB4 | 2.96107971 |
| 11 | INSRR | 2.95789901 |
| 12 | TLK1 | 2.59032101 |
| 13 | WNK4 | 2.58731774 |
| 14 | WNK3 | 2.45511961 |
| 15 | MAP4K2 | 2.38086323 |
| 16 | MAP2K4 | 2.33717718 |
| 17 | PKN2 | 2.24916372 |
| 18 | MST1R | 2.09323471 |
| 19 | NUAK1 | 1.95786345 |
| 20 | FLT3 | 1.95084418 |
| 21 | MAPK11 | 1.93441616 |
| 22 | PIK3CG | 1.78242384 |
| 23 | TRIB3 | 1.73520230 |
| 24 | TYK2 | 1.70512595 |
| 25 | CASK | 1.69965349 |
| 26 | MAPK13 | 1.68901855 |
| 27 | LATS1 | 1.67037856 |
| 28 | OXSR1 | 1.65817691 |
| 29 | MAP3K4 | 1.58763147 |
| 30 | ABL2 | 1.50438289 |
| 31 | DAPK2 | 1.50103325 |
| 32 | PTK6 | 1.43248977 |
| 33 | TXK | 1.43223392 |
| 34 | FGFR2 | 1.41436226 |
| 35 | NEK9 | 1.35677495 |
| 36 | NTRK3 | 1.35176361 |
| 37 | FRK | 1.33599434 |
| 38 | ADRBK1 | 1.31341016 |
| 39 | PINK1 | 1.30772425 |
| 40 | KDR | 1.30130799 |
| 41 | MKNK2 | 1.26115185 |
| 42 | JAK2 | 1.23682714 |
| 43 | STK39 | 1.19908708 |
| 44 | MAP3K7 | 1.18184470 |
| 45 | PRKAA2 | 1.14081970 |
| 46 | TGFBR1 | 1.12743806 |
| 47 | DYRK2 | 1.09562461 |
| 48 | PIK3CA | 1.08067463 |
| 49 | TNIK | 1.06370193 |
| 50 | CAMKK2 | 1.05733660 |
| 51 | MAP2K3 | 1.05301120 |
| 52 | MAPK15 | 1.04774199 |
| 53 | GRK6 | 1.04757275 |
| 54 | TBK1 | 1.03232153 |
| 55 | ERBB2 | 1.02366245 |
| 56 | MAPK4 | 1.01636297 |
| 57 | MAP3K10 | 1.00947317 |
| 58 | JAK1 | 1.00460208 |
| 59 | MAP3K14 | 0.96266099 |
| 60 | PAK3 | 0.94740811 |
| 61 | PRKCZ | 0.94541486 |
| 62 | TNK2 | 0.90218233 |
| 63 | STK16 | 0.89330095 |
| 64 | STK38L | 0.89282903 |
| 65 | MAP3K11 | 0.88565435 |
| 66 | MET | 0.86064660 |
| 67 | CDK6 | 0.85552546 |
| 68 | PRKCE | 0.85229407 |
| 69 | MAP3K3 | 0.84851250 |
| 70 | MUSK | 0.83818233 |
| 71 | VRK1 | 0.83630785 |
| 72 | MAPKAPK3 | 0.82256880 |
| 73 | MAPK12 | 0.79398370 |
| 74 | EPHB1 | 0.79056154 |
| 75 | CSK | 0.78899771 |
| 76 | PRKACG | 0.76574995 |
| 77 | DYRK1B | 0.75956419 |
| 78 | MAP2K7 | 0.75314201 |
| 79 | TIE1 | 0.74647582 |
| 80 | CAMK2G | 0.74507296 |
| 81 | RPS6KA5 | 0.70879007 |
| 82 | EPHA3 | 0.70865022 |
| 83 | GSK3A | 0.70807774 |
| 84 | PRKAA1 | 0.68819956 |
| 85 | CAMK1D | 0.68461022 |
| 86 | MAP2K6 | 0.67001459 |
| 87 | PHKG2 | 0.66599048 |
| 88 | PHKG1 | 0.66599048 |
| 89 | PRKACA | 0.64193710 |
| 90 | SGK3 | 0.63078826 |
| 91 | IRAK3 | 0.60054745 |
| 92 | RIPK1 | 0.60030250 |
| 93 | BRSK2 | 0.59215817 |
| 94 | MAPKAPK5 | 0.58843280 |
| 95 | MAPK7 | 0.58238244 |
| 96 | ICK | 0.57470899 |
| 97 | MARK1 | 0.57320559 |
| 98 | PDK2 | 0.56787491 |
| 99 | TEC | 0.56369219 |
| 100 | STK11 | 0.56168681 |
| 101 | FGFR3 | 0.55702655 |
| 102 | CSF1R | 0.55553964 |
| 103 | IKBKB | 0.54961942 |
| 104 | TGFBR2 | 0.54532354 |
| 105 | PTK2 | 0.54248981 |
| 106 | MAP3K6 | 0.53827486 |
| 107 | TRIM28 | 0.53752734 |
| 108 | CSNK1G1 | 0.53435985 |
| 109 | IKBKE | 0.52961123 |
| 110 | NME1 | 0.51946172 |
| 111 | TAOK2 | 0.51916520 |
| 112 | CSNK1A1 | 0.50738058 |
| 113 | CSNK1D | 0.50299074 |
| 114 | PTK2B | 0.50128684 |
| 115 | PRKCQ | 0.50013121 |
| 116 | PDPK1 | 0.49965363 |
| 117 | EPHA4 | 0.48927004 |
| 118 | SGK2 | 0.44626361 |
| 119 | CAMK1 | 0.44484904 |
| 120 | PNCK | 0.44454186 |
| 121 | MAP3K5 | 0.44438306 |
| 122 | GRK1 | 0.43789435 |
| 123 | IGF1R | 0.42470881 |
| 124 | CDK4 | 0.41952835 |
| 125 | PRKG1 | 0.41732243 |
| 126 | CAMK2A | 0.41396856 |
| 127 | PRKCG | 0.40388996 |
| 128 | ATR | 0.40080722 |
| 129 | MAP2K1 | 0.39643119 |
| 130 | PKN1 | 0.39415722 |
| 131 | MKNK1 | 0.39184568 |
| 132 | RET | 0.39017149 |
| 133 | NLK | 0.38967337 |
| 134 | MAP3K13 | 0.38845849 |
| 135 | MTOR | 0.37327395 |
| 136 | SIK2 | 0.36933887 |
| 137 | PLK2 | 0.35780629 |
| 138 | EGFR | 0.35578072 |
| 139 | CHUK | 0.35004912 |
| 140 | CAMK1G | 0.34364763 |
| 141 | PRKCI | 0.34290607 |
| 142 | LATS2 | 0.33347943 |
| 143 | NEK2 | 0.32722279 |
| 144 | DYRK1A | 0.32386507 |
| 145 | OBSCN | 0.32280492 |
| 146 | SGK1 | 0.31581002 |
| 147 | CAMK4 | 0.31434088 |
| 148 | CAMKK1 | 0.31379070 |
| 149 | CSNK1G2 | 0.31321497 |
| 150 | PBK | 0.31084452 |
| 151 | PDK1 | 0.30500278 |
| 152 | PRKACB | 0.30221402 |
| 153 | VRK2 | 0.30094392 |
| 154 | SGK223 | 0.29513339 |
| 155 | SGK494 | 0.29513339 |
| 156 | RPS6KA3 | 0.29456842 |
| 157 | CSNK1G3 | 0.29088464 |
| 158 | BMX | 0.27925535 |
| 159 | PRKCA | 0.25376835 |
| 160 | IRAK2 | 0.24250115 |
| 161 | AKT3 | 0.23373052 |
| 162 | ABL1 | 0.22582794 |
| 163 | IRAK1 | 0.22249393 |
| 164 | MAP3K1 | 0.22059987 |
| 165 | MAP2K2 | 0.19997845 |
| 166 | CSNK1A1L | 0.19733077 |
| 167 | PDK3 | 0.19694512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38719994 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62928220 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40458081 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38790067 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11276385 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77827953 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70200744 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69730414 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63072663 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55777787 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47746312 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37324851 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28273740 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15732981 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14302694 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07867880 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97240107 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95559051 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95207270 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91452739 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91181134 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80589125 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.80215805 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78503914 |
| 25 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77674722 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77373760 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76500216 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73366200 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71263541 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67724160 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59296127 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57576348 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56856018 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52529504 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51391096 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44677187 |
| 37 | * Bile secretion_Homo sapiens_hsa04976 | 1.40262450 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35289105 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34785095 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33518539 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32957541 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29561910 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23293135 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22650216 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22096006 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.20709307 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15113698 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12205377 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05898026 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00668170 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98585693 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97984755 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97654548 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97461120 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96270560 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.89931892 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87956599 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85978402 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84765402 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83372937 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.81394462 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77536931 |
| 63 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.75657800 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69245825 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67051336 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66872773 |
| 67 | Nicotine addiction_Homo sapiens_hsa05033 | 0.65305861 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65071894 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58764176 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57933739 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57915722 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57325081 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.51981112 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.50703746 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50617936 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47860394 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47389632 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46947788 |
| 79 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45533358 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45439058 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39818186 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38804539 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.37260352 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.31303542 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30417522 |
| 86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27170837 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.25682500 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25044068 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24863628 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23787693 |
| 91 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23738228 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22543088 |
| 93 | Protein export_Homo sapiens_hsa03060 | 0.22293814 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21571411 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.21357773 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19659975 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.19411577 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19286366 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.18777212 |
| 100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.18204733 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16257888 |
| 102 | * Insulin resistance_Homo sapiens_hsa04931 | 0.16088244 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.12879907 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09437875 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.09318631 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.08381239 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.07139985 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.07032905 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02005547 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | -0.2499695 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.2410437 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2316896 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2314447 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2308138 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2035115 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2006871 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1983055 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1955635 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | -0.1828161 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1688023 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1539777 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1537000 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1460439 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1435228 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1308495 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0993467 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0958222 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0720124 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0683170 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0514788 |

